ACTIVATED CASPASE-1 IS NOT A CENTRAL MEDIATOR OF INFLAMMATION IN THE COURSE OF ISCHEMIA-REPERFUSION1
- 1 March 2001
- journal article
- immunobiology
- Published by Wolters Kluwer Health in Transplantation
- Vol. 71 (6) , 778-784
- https://doi.org/10.1097/00007890-200103270-00016
Abstract
Background. Upon transplantation, donor organs subjected to prolonged ischemia suffer from reperfusion injury. Recent observations suggest that caspase activation is involved in inducing the deleterious inflammatory reaction that mediates reperfusion injury. Release of cytokines like interleukin (IL)-1 and IL-18 may occur during apoptosis through activation of caspase-1/IL-1β-converting enzyme. We hypothesized that caspase-1 activation is a key event in apoptosis/caspase-dependent inflammation during the development of renal reperfusion injury. Methods. Caspase-1-/-, caspase-1+/+ as well as Swiss mice were subjected to 45 min of renal ischemia and 24 hr of reperfusion. Animals were administered agents capable of neutralizing the pro-inflammatory activation products of caspase-1 (IL-1 receptor antagonist, anti-IL-1 receptor antibody, and anti-IL-18 antibody). The extent of renal functional deterioration, inflammation, and apoptosis were compared. Results. No improvement in renal function as reflected by serum ureum and creatinine were found in caspase-1-/- mice as compared to wild type controls. Caspase-1-/- mice showed slightly attenuated renal inflammation as indicated by decreased renal neutrophil influx, but failed to show changes in intra- renal tumor necrosis factor-α production. Moreover, caspase-1-/- mice clearly exhibited reperfusion-induced apoptosis as reflected by renal terminal deoxynucleotidyltransferase histology and internucleosomal DNA cleavage. Treatment with IL-1 receptor antagonist, anti-IL-1 receptor antibody, or anti-IL-18 antibody minimally reduced renal functional deterioration, inflammation, and apoptosis. Conclusions. These findings suggest that activated caspase-1 and its inflammatory products are involved in, but not crucial to, the induction of inflammation after renal ischemia-reperfusion. Hence, apart from caspase-1, other (combinations of) activated caspases are likely to be more prominently involved in renal reperfusion injury.Keywords
This publication has 25 references indexed in Scilit:
- Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammationJournal of Clinical Investigation, 1999
- INVOLVEMENT OF ENDOGENOUS INTERLEUKIN-10 AND TUMOR NECROSIS FACTOR-?? IN RENAL ISCHEMIA-REPERFUSION INJURY1,2Transplantation, 1999
- Caspase‐1 is not involved in experimental hepatitis in mouseFEBS Letters, 1999
- Caspase 1-independent IL-1β release and inflammation induced by the apoptosis inducer Fas ligandNature Medicine, 1998
- Cell death attenuation by `Usurpin', a mammalian DED-caspase homologue that precludes caspase-8 recruitment and activation by the CD-95 (Fas, APO-1) receptor complexCell Death & Differentiation, 1998
- The cytokine-adhesion molecule cascade in ischemia/reperfusion injury of the rat kidney. Inhibition by a soluble P-selectin ligand.Journal of Clinical Investigation, 1997
- Acute Renal FailureNew England Journal of Medicine, 1996
- Antibodies to ICAM-1 Protect Kidneys in Severe Ischemic Reperfusion InjuryBiochemical and Biophysical Research Communications, 1995
- Mice deficient in IL-1β-converting enzyme are defective in production of mature IL-1β and resistant to endotoxic shockCell, 1995
- Molecular Cloning of the Interleukin-1β Converting EnzymeScience, 1992